Microglial autophagy-associated phagocytosis is essential for recovery from neuroinflammation

Area of Science:

• Neuroscience
• Immunology
• Cell Biology

Background:

• Multiple sclerosis (MS) is a progressive neurodegenerative disease impacting young adults.
• Microglia, immune cells in the central nervous system (CNS), clear debris but decline with age, correlating with MS progression.
• The mechanisms linking age-related microglial dysfunction to MS progression are not fully understood.

Purpose of the Study:

• To investigate the role of microglial autophagy in clearing myelin debris and recovery from CNS inflammation in a murine model of MS.
• To explore the therapeutic potential of enhancing microglial autophagy for age-related neuroinflammatory conditions.

Main Methods:

• Utilized a murine model of MS with microglia-specific deletion of autophagy regulators (Atg7 and Ulk1).
• Analyzed microglial debris clearance capacity, transcriptional profiles, and disease progression.
• Investigated the effect of trehalose, an autophagy inducer, on aged mice with MS-like pathology.

Main Results:

• Microglia-specific deletion of Atg7, but not Ulk1, impaired myelin debris clearance, leading to progressive MS-like disease.
• Atg7-deficient microglia exhibited phenotypes similar to aged microglia, unable to clear myelin or recover from inflammation.
• Trehalose treatment induced autophagy, restored myelin clearance, and led to disease remission in aged mice.

Conclusions:

• A noncanonical form of autophagy in microglia is crucial for myelin degradation and clearance, facilitating recovery from MS-like disease.
• Enhancing microglial autophagy presents a potential therapeutic strategy for age-related neuroinflammatory diseases like MS.